National Health Investors (NYSE:NHI) Posts Earnings Results, Misses Expectations By $0.42 EPS

National Health Investors (NYSE:NHI - Get Free Report) posted its earnings results on Tuesday. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42), Zacks reports. The company had revenue of $63.32 million during the quarter, compared to analysts' expectations of $67.93 million. National Health Investors had a net margin of 39.11% and a return on equity of 10.11%. National Health Investors's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.08 EPS. National Health Investors updated its FY24 guidance to $4.43-$4.44 EPS and its FY 2024 guidance to 4.430-4.440 EPS.

National Health Investors Stock Performance

NHI stock traded up $2.82 on Thursday, hitting $79.58. The company's stock had a trading volume of 191,765 shares, compared to its average volume of 193,590. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock has a market cap of $3.46 billion, a price-to-earnings ratio of 26.11, a price-to-earnings-growth ratio of 5.05 and a beta of 1.05. National Health Investors has a 1 year low of $49.25 and a 1 year high of $86.13. The firm has a 50 day moving average of $80.38 and a two-hundred day moving average of $73.16.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 4.52%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors's dividend payout ratio (DPR) is 122.45%.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of analyst reports. Wells Fargo & Company downgraded shares of National Health Investors from an "overweight" rating to an "equal weight" rating and lifted their price objective for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Bank of America assumed coverage on National Health Investors in a research report on Tuesday, September 24th. They set a "buy" rating and a $92.00 price target on the stock. Truist Financial raised their price objective on National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a research report on Friday, August 30th. Finally, StockNews.com lowered National Health Investors from a "buy" rating to a "hold" rating in a research report on Tuesday, October 15th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $73.29.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.